A novel oncogenic enhancer of estrogen receptor-positive breast cancer.
Ontology highlight
ABSTRACT: Estrogen receptor-positive (ER+) breast cancer accounts for the majority of breast cancers diagnosed, and nearly 20% of patients do not respond to endocrine therapy. The pathogenesis of ER+ breast cancer has not been well elucidated. The enhancer is a cis-regulatory element that promotes gene transcription and plays an important role in the spatiotemporal expression of cellular genes. Nevertheless, the oncogenic enhancer and its role in the occurrence and progression of cancer remain unclear. Here, we report a novel oncogenic enhancer (named αE myc ) for c-Myc and reveal its activation mechanism in ER+ breast cancer. The results demonstrated that αE myc enhanced the transcription of downstream genes more tha
SUBMITTER: Bao C
PROVIDER: S-EPMC9463563 | biostudies-literature | 2022 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA